Related Experiment Video

Updated: Jul 7, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

Protochlamydia naegleriophila as etiologic agent of pneumonia

Nicola Casson1, Rolf Michel, Karl-Dieter Müller

  • 1Center for Research on Intracellular Bacteria, Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.

Emerging Infectious Diseases
|February 9, 2008
PubMed

Insights

Researchers identified a novel bacterium, Protochlamydia naegleriophila, living with amoeba. A new diagnostic test detected this bacteria in a pneumonia patient, suggesting a potential link needing further investigation.

Area of Science:

  • Microbiology
  • Bacteriology
  • Amoeba Symbiosis

Background:

  • Amoeba-associated bacteria are increasingly recognized.
  • The diversity and pathogenic potential of amoeba endosymbionts remain underexplored.

Purpose of the Study:

  • To isolate and characterize a novel endosymbiont from Naegleria amoebae.
  • To develop a diagnostic tool for identifying Protochlamydia species.
  • To investigate the presence of Protochlamydia in human respiratory infections.

Main Methods:

  • Coculture of Naegleria amoebae with potential endosymbionts.
  • Phenotypic, genetic, and phylogenetic analyses for bacterial identification.
  • Development and application of a species-specific Polymerase Chain Reaction (PCR) assay.
  • Testing of bronchoalveolar lavage samples from pneumonia patients.

Main Results:

  • Isolation and successful cultivation of a Naegleria endosymbiont.
  • Identification of the endosymbiont as Protochlamydia naegleriophila sp. nov. based on comprehensive analyses.
  • Development of a sensitive and specific PCR diagnostic for Protochlamydia spp.
  • Detection of Protochlamydia DNA in a bronchoalveolar lavage sample from a pneumonia patient.

Conclusions:

  • Protochlamydia naegleriophila represents a newly identified bacterial species.
  • A novel diagnostic PCR assay for Protochlamydia spp. has been established.
  • The presence of Protochlamydia in a pneumonia case warrants further research into its potential role in respiratory disease.

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: